Correction to: FOXO3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis

Affiliations

¹ Department of Hepatobiliary Surgery, The Xianyang Central Hospital, Xianyang, Shaanxi, China.
² Department of Oncology, The Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Putuo, Shanghai, China.
³ Department of Oncology, The Affiliated Hospital of the Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China.
⁴ Department of Oncology, The Affiliated Hospital of the Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China. xhjdoc@163.com.

^# Contributed equally.

Published Erratum

Lin Yang et al. Cancer Gene Ther. 2022 Aug.

. 2022 Aug;29(8-9):1301.

doi: 10.1038/s41417-022-00468-z.

¹ Department of Hepatobiliary Surgery, The Xianyang Central Hospital, Xianyang, Shaanxi, China.
² Department of Oncology, The Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Putuo, Shanghai, China.
³ Department of Oncology, The Affiliated Hospital of the Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China.
⁴ Department of Oncology, The Affiliated Hospital of the Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China. xhjdoc@163.com.

^# Contributed equally.

No abstract available

Erratum for

FOXO3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis.
Yang L, Deng WL, Zhao BG, Xu Y, Wang XW, Fang Y, Xiao HJ. Yang L, et al. Cancer Gene Ther. 2022 Mar;29(3-4):326-340. doi: 10.1038/s41417-021-00312-w. Epub 2021 Mar 2. Cancer Gene Ther. 2022. PMID: 33654226 Free PMC article.